Clinical Trials Logo

Clinical Trial Summary

Efficacy and Safety of Imsidolimab (ANB019) in Subjects with Hidradenitis Suppurativa


Clinical Trial Description

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of imsidolimab in adult subjects with hidradenitis suppurativa (HS). This study also will characterize the pharmacokinetic (PK) profile of imsidolimab and explore the immune response to imsidolimab in subjects with HS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04856930
Study type Interventional
Source AnaptysBio, Inc.
Contact Angela Iheanacho, MS
Phone (240) 676-3114
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date May 2021
Completion date April 2023

See also
  Status Clinical Trial Phase
Completed NCT02904902 - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Phase 3
Completed NCT03628924 - A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Phase 2
Completed NCT03275870 - Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Phase 1/Phase 2
Completed NCT03248531 - A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Phase 2
Withdrawn NCT04100083 - Spironolactone for Hidradenitis Suppurativa Phase 4
Not yet recruiting NCT04508374 - Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa N/A
Not yet recruiting NCT04061395 - Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. Phase 2
Completed NCT00329823 - Etanercept in Hidradenitis Suppurativa Phase 2
Completed NCT04019041 - A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa Phase 2
Recruiting NCT04325607 - Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa N/A
Terminated NCT03238469 - Microwave Ablation in Mild Axillary Hidradenitis Suppurativa N/A
Completed NCT04449354 - HidraWear AX HS Study N/A
Recruiting NCT04246372 - Tofacitinib for Immune Skin Conditions in Down Syndrome Phase 2
Completed NCT01516749 - Anakinra as a Treatment for Hydradenitis Suppurativa Phase 2
Terminated NCT00722800 - A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS Phase 2
Completed NCT00395187 - A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa N/A
Completed NCT04600375 - Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa N/A
Completed NCT03607487 - A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Phase 2
Not yet recruiting NCT04541550 - Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa Phase 1
Recruiting NCT03553888 - Hidradenitis Suppurativa and Periodontal Diseases